Navigation Links
GENSPEED Biotech and axiVEND Announce a Collaboration Agreement
Date:8/1/2019

The GENSPEED platform is a compact, fast and simple system to enable multiplex testing at the point of care. It is fully developed with over 100 units deployed in the field for multiple applications. “Beyond the creation of new tests, with applications into new fields of use, our collaboration with axiVEND will give us a foothold in the USA to better support other nascent test development opportunities,” said Max Sonnleitner, GENSPEED Biotech CEO. “We are excited about our collaboration with axiVEND and the expanded reach this will provide us.”

“The platform itself is very promising, leveraging simple microfluidic consumables and associated ease of use,” said Claude Dufresne, axiVEND CEO. “This platform gives us the fastest and best probability of success to bring novel multiplex test ideas to the market. We will market the new tests under the brand axiTESTtm and use the GENSPEED platform as an OEM system, branded with axiTESTtm colors. This is an exciting phase for both companies.”

About GENSPEED Biotech
GENSPEED Biotech was founded in 2016 as a spin-off company of Greiner Bio-One. We develop, produce and distribute IVD-certified rapid testing solutions based on the patented GENSPEED® technology.. Currently, nine highly qualified employees are devoted to the development, production and sales of in-vitro diagnostics for the rapid identification of various pathogens. With its novel combination of microfluidics, miniaturized opto-electronics and automation GENSPEED® enables the simultaneous detection of multiple analytes at the point of care within a few minutes. GENSPEED® may be used for nucleic acid-based genetic testing as well as for protein analyses. Thus, the platform facilitates the rapid identification of defined bacteria or viruses as well as the quantitation of certain biomarkers in blood or other biological material. For additional information please visit http://www.genspeed-biotech.com.

About axiVEND
While newly founded in 2019, axiVEND is built on the concept of truth in vending. From the Greek “axios” for truthfulness, axiVEND promises to provide the very best solutions, with proven field performance, to the worlds of diagnostics and multiplex assays. Leveraging an expanded network throughout North and South America, axiVEND will soon be positively impacting life science industries in general. The early axiVEND portfolio encompasses best-in-class M2 Automation ultra-low volume high-precision liquid deposition technologies, the latest offerings in colorimetric and fluorescence multiplex array readers, unique high-performance surface coatings for superior protein functional activity, and the next generation label-free multiplex reader. For additional information please visit the axiVEND website at http://www.axivend.com, and follow us on LinkedIn.

Read the full story at https://www.prweb.com/releases/genspeed_biotech_and_axivend_announce_a_collaboration_agreement/prweb16479709.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. KMK Consulting, Inc. Expands Presence in Boston to Help Biotechnology Companies from Pre-Launch to Commercialization
2. Lifecycle Biotechnologies Announces Cellular Agriculture Expansion
3. Swiss Biotech Gnubiotics, Announces Global Launch of GNU100 the First Microbiome Specialty Ingredient for Companion Animal Gut Health
4. Jessica Wein Joins Lifecycle Biotechnologies As Marketing Strategist
5. Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space
6. Lifecycle Biotechnologies Announces Promotion of Cindy Baptiste to Business Development Manager
7. Lifecycle Biotechnologies Releases Company Catalog
8. Lifecycle Biotechnologies Launches 100-Liter SAFEthread Drum
9. Avastus Opens New Vivarium to Serve the Preclinical Research Needs of Boston’s Biotech Community
10. Biotech Automation and FDA Validation Expert Superior Controls to Exhibit and Recruit at the ISPE Annual Premier One-Day Biopharmaceutical Show on September 26
11. Dickinson Wright Attorney Lance Anderson Named Pharmaceuticals and Biotechnology Practice Group Chair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2019)... ... August 14, 2019 , ... An upcoming episode of Advancements ... therapeutics are helping to promote normal immune function in order to prevent and ... about the DECODE.DESIGN.CURE™ technology platform, which rapidly develops microbiome therapeutics in order to ...
(Date:8/14/2019)... ... ... Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel Research in ... learn about two common imaging methods in NAFLD/NASH to aid with early disease diagnosis, ... disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided into simple ...
(Date:8/14/2019)... ... August 14, 2019 , ... Gateway Genomics , a ... announces inclusion in the 38th annual Inc. 500|5000 list of fastest growing ... qualify, companies must have been founded and generating revenue by March 31, 2015. Ranking ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... SOMERSET, N.J. (PRWEB) , ... September 17, 2019 ... ... today announced that Julie Delaney, Director, Project and Clinical Supplies Management, Asia Pacific ... at the One Farrer Hotel, Singapore, on Sept. 25-26, 2019. , On Thursday, ...
(Date:9/17/2019)... ... September 16, 2019 , ... ... CNBC on Saturday, September 21st @11:00am ET. Check local listings for more information ... (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to developing advanced ...
(Date:9/11/2019)... SOMERSET, N.J. (PRWEB) , ... September 10, 2019 ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health ... Pharma Forum, to be held at the Bausparkasse Schwäbisch Hall AG, Schwabisch Hall, ...
(Date:9/2/2019)... DENVILLE, N.J. and LIÉGE, Belgium (PRWEB) , ... ... ... provider of solutions for epigenetics research and in vitro diagnostics, has launched the ... to uncover the underlying biological meaning of epigenetic data and other data ...
Breaking Biology Technology: